About DEMECAN
DEMECAN is a company based in Berlin (Germany) founded in 2017 by Constantin Von Der Groeben, Adrian Fischer, and Cornelius Maurer. DEMECAN has raised $7.64 million across 1 funding round from investors including b2venture. DEMECAN offers products and services including Medical Cannabis Products, Patientenausweis, and Apotheken-Finder. DEMECAN operates in a competitive market with competitors including Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and Alphargreen Group Limited, among others.
- Headquarter Berlin, Germany
- Founders Constantin Von Der Groeben, Adrian Fischer, Cornelius Maurer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.64 M (USD)
in 1 rounds
-
Latest Funding Round
$7.64 M (USD), Series A
Oct 01, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DEMECAN
DEMECAN offers a comprehensive portfolio of products and services, including Medical Cannabis Products, Patientenausweis, and Apotheken-Finder.
High-quality cannabis for medical therapy and patient treatment
Secure digital ID for identifying medical cannabis patients
Tool to locate pharmacies offering cannabis-related services
People of DEMECAN
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of DEMECAN
DEMECAN has successfully raised a total of $7.64M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.64 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DEMECAN
DEMECAN has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include b2venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is provided to innovative startups by b2venture.
|
Locked | Locked | Locked |
Investor details for DEMECAN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DEMECAN
Investment portfolio details for DEMECAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DEMECAN
Detailed financials for DEMECAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Demecan Comparisons
Peer comparison for DEMECAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DEMECAN
DEMECAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vireo Health, Demetrix, Nutritional High, THE BEEMINE LAB and Alphargreen Group Limited, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cannabis plants are cultivated in greenhouses for wellness product development.
|
|
| Locked | Locked | Locked |
Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology.
|
|
| Locked | Locked | Locked |
Cannabis-infused products are developed, manufactured, and distributed for consumers.
|
|
| Locked | Locked | Locked |
Cannabis-derived nutritional and wellness products are offered online.
|
|
| Locked | Locked | Locked |
Online marketplace for cannabis products treating various diseases is operated.
|
Detailed competitors of DEMECAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Demecan
Complete news archive for DEMECAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DEMECAN
DEMECAN was founded in 2017 and raised its 1st funding round 2 years after it was founded.
DEMECAN is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
DEMECAN is a funded company, having raised a total of $7.64M across 1 funding round to date.
DEMECAN, backed by 7641380.0 from b2venture, focuses on healthtech, cannabis healthtech, providing healthcare solutions, and nutraceuticals. Producer of medical cannabis. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
DEMECAN's top competitors include Vireo Health, Alphargreen Group Limited and Demetrix.
DEMECAN offers Medical Cannabis Products, Patientenausweis, and Apotheken-Finder.
DEMECAN has 1 investor. Key investors include b2venture.